![Researchers proposing ideas via sticky note at the Cure CRC Summit](/sites/default/files/styles/2056x798/public/media/images/summit3.png.webp?itok=6h3Pb2JQ)
Project Cure CRC
![Researcher brainstorming ideas for ways to end colorectal cancer at the Cure CRC Summit](/sites/default/files/styles/fifty_fifty/public/media/images/summit4.png.webp?itok=0RjuwQvR)
Request for Proposals
Project Cure CRC has announced a rolling Request for Proposals (RFP), making available tens of millions of dollars to academic and industry researchers whose work aims to expedite colorectal cancer research to a curable science. Download the RFP for details and submit your proposal at ProposalCentral.
![A researcher speaks on a microphone at the Cure CRC Summit](/sites/default/files/styles/fifty_fifty/public/media/images/summit5.png.webp?itok=rfOfp_3m)
Hope for today's patients
With bold and urgent action, Project Cure CRC seeks to cultivate breakthroughs in colorectal cancer diagnosis, treatment, metastasis, and survivorship. The project will ignite innovative treatments to end colorectal cancer now.
Funded research
![A doctor sitting at his desk explaining his medical research](/sites/default/files/styles/680x378/public/media/images/kullari-video-image.png.webp?itok=3IOPG341)
Raghu Kalluri, MD, PhD
Dr. Kalluri of MD Anderson Cancer Center aims to develop urgently needed therapeutic options for the 96% of colorectal cancer patients with microsatellite stable (MSS) disease.
![A picture of H. Charles Manning of MD Anderson Cancer Center](/sites/default/files/styles/680x378/public/media/images/charles-manning.png.webp?itok=-er1OQfo)
H. Charles Manning, PhD
H. Charles Manning, PhD, a professor at MD Anderson Cancer Center, will lead a collaborative effort to discover the first theranostic pair for imaging and therapy for patients with CRC.
![Researchers networking, speaking and thinking around a table at the Cure CRC Summit](/sites/default/files/styles/fifty_fifty/public/media/images/summit2.png.webp?itok=0FNpVejj)
Cure CRC Summit
In December 2023, the Cure CRC Summit welcomed more than 100 prominent scientists to foster partnerships that will challenge the status quo of colorectal therapies and discover new trajectories toward a cure.
Project Cure CRC Co-ChairsMichael Sapienza Alliance Project LeadDavid Fenstermacher, PhD | Scientific Co-ChairsJohn Marshall, MD Scott Kopetz, MD, PhD, FACP Christopher Lieu, MD Patient Advocate Co-ChairJohn Woerner |
Grant Review CommitteeJ. Randolph Hecht, MD Scott Kopetz, MD, PhD, FACP Christopher Lieu, MD | John Marshall, MD Alan P. Venook, MD |
![Colorectal Cancer Alliance Launches Project Cure CRC](/sites/default/files/styles/fifty_fifty/public/media/images/article/project-cure-crc.png.webp?itok=OeIDa2lF)
Support the project
The Colorectal Cancer Alliance invites the public, corporations, foundations, and philanthropic individuals to join us by contributing to Project Cure CRC.
Top resources
![The United States Capitol Building in Washington, D.C.](/sites/default/files/styles/450x250/public/media/images/us-capitol_0.png.webp?itok=dbbF7yeZ)
Alliance supports the Clinical Trials Modernization Act
This bipartisan legislation aims to improve participation in clinical trials by addressing major barriers such as non-medical expenses, trial location accessibility, diverse participation, and financial implications for patients.
![23andMe and Colorectal Cancer Alliance logos](/sites/default/files/styles/450x250/public/media/images/23andme-colorectalcanceralliance-light-blue.png.webp?itok=aQs0x-cp)
23andMe and the Alliance team up on cancer research
The collaboration aims to raise awareness, encourage screening, and help people better understand their risks.
![23andMe and Colorectal Cancer Alliance logos](/sites/default/files/styles/450x250/public/media/images/23andme-colorectalcanceralliance.png.webp?itok=GigcGZdo)
The Alliance and 23andMe Collaborate to Help Advance CRC Research in the Black Community
With 23andMe, the Alliance seeks another avenue to educate Black communities about the importance of knowing their family health history and risk factors to prevent colorectal cancer or find it at an early stage when it is most treatable.